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Introduction
Heart failure (HF) represents a major cause of morbidity and mortality in western countries. In the United States, approximately 5 million people have HF and 550,000 each year are newly diagnosed with the condition [1] . Patients with HF experience nearly 1,100,000 annual hospitalizations for HF [2] . In-hospital mortality represents an understudied component of HF-related adverse outcomes. Reported mortality rates during hospitalization vary widely depending on population profile and HF diagnostic criteria [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . In the EuroHeart Failure Survey programme, which included patients from 24 countries in Europe, in-hospital mortality rates ranged from 1.3% to 10.2% [3] . Moreover, heart failure with preserved ejection fraction (HFPEF) is an increasingly prevalent form, responsible for approximately 50% of all admissions for decompensated HF [3] [4] [5] 13] . Scarce data are available on inhospital outcome of patients with HFPEF [14] .
The objectives of this hospital-based observational study, which prospectively included patients admitted for a first episode of HF in all establishments managing HF patients in a single French department, were: 1) to describe the clinical characteristics of patients admitted to hospital with a new diagnosis of HF, 2) to assess the in-hospital mortality in this cohort and to identify independent predictive factors of adverse in-hospital outcome, and 3) to compare the in-hospital mortality of patients with HFPEF with that of patients with HF and reduced left ventricular (LV) ejection fraction (EF).
Methods

Population and inclusion criteria
Somme is a fairly rural department in the north of France with a population of 555,551 inhabitants according to the 1999 census. There are 11 healthcare establishments managing patients with HF: 1 university hospital, 7 general hos- pitals, 2 private clinics and 1 medium and long-stay unit. General practitioners, cardiologists and internal physicians in these centres agreed to participate in this study. Consecutive patients older than 20 years, hospitalized for a first episode of HF in any of these centres during 2000 were enrolled prospectively. Patients living outside Somme, patients hospitalized for subsequent episodes of HF, and patients with severe valvular disease requiring surgery were excluded. We also excluded patients hospitalized primarily for acute myocardial infarction. The diagnosis of HF was made by the attending physician in 811 patients, based on history, symptoms, physical signs and chest X-ray on admission. Two cardiologists, specifically recruited for this purpose, reviewed during the index hospitalization all medical records in order to validate the diagnosis of HF according to the Framingham criteria amended by the European Society of Cardiology [15] . The diagnosis was validated in 799 patients (410 men and 389 women) who comprise the study population.
Abbreviations
Data collection
Clinical data including medical history, cardiovascular risk factors, and results of complementary investigations (laboratory tests, electrocardiogram, chest X-ray on admission, echocardiography, and in some patients, coronary angiography) were recorded on individual case-report forms. EF was determined during the index hospitalization in 662 patients (83%) by echocardiography (n=648) and/or left ventriculography (n=103). Echocardiograms were recorded according to the guidelines of the American Society of Echocardiography [16] . When more than one method was performed, an average EF was calculated. A cut-off of 50% was used to distinguish HFPEF from HF with reduced EF [17] [18] [19] [20] . An estimate of glomerular filtration rate on admission was calculated using the simplified Modification of Diet in Renal Disease formula [21] . In-hospital mortality rates were determined. Causes of death were ascertained from hospital records and autopsy records.
Statistical analysis
Continuous variables are expressed as mean±standard deviation and were compared using Student's t-test. Categorical variables are summarized by frequency percents and were analysed by the χ 2 test or Fisher's exact test, as appropriate. Univariate analyses tested all baseline characteristics that potentially could be associated with in-hospital mortality. For multivariable analyses, we used a logistic regression model that included variables considered of potential prognostic importance (age, sex, history of hypertension, coronary artery disease, diabetes mellitus, chronic obstructive pulmonary disease, stroke, cancer, systolic blood pressure [SBP] on admission, heart rate [HR] on admission, natraemia) and variables significantly associated with in-hospital death on univariate analysis. The forward stepwise procedure (significance levels of 0.05 for entry and 0.1 for removal) was applied to calculate odds ratios and 95% confidence intervals for the set of variables independently associated with an adverse in-hospital outcome. A separate logistic regression model was run in patients in whom EF data were available.
The significant imbalance in baseline variables between patients with preserved or reduced EF was lowered using propensity scores. We estimated the propensity scores for each of the 294 patients with reduced EF using a multivariable logistic model, as previously described [22, 23] . Characteristics associated with the presence of reduced EF on univariate analysis (p≤0.15) were included in the multivariable logistic model in a forward stepwise regression analysis. Using the resulting selected variables, a propensity score for each patient was estimated by maximum likelihood regression analysis. The propensity scores were used to match each patient with reduced EF to a unique patient with preserved EF with a propensity score within 2%. First we matched each patient with reduced EF with another in the preserved EF group that had the same 5-digit propensity score and removed the matched patients from the database. The procedure was repeated in the remaining patients with successive matching by 4-, 3-, and 2-digit scores. One-hundred and eighty five (63%) of the 294 patients with reduced EF were successfully matched. The mean propensity score in patients with reduced EF before matching was 0.56649 compared to 0.34345 in those with preserved EF (p<0.001). In the group that resulted after matching, the mean propensity score was 0.47425 in patients with reduced EF, comparable to that of the preserved EF group (0.47502; p=0.97). Baseline characteristics of the groups resulting after matching were compared using Student's t test and the χ 2 test, as appropriate. Goodness-of-fit (Hosmer-Lemeshow test) and discriminatory power (area under the receiver-operating characteristic curve, C) were assessed for all multivariable logistic models. For all tests, a p-value (two-sided) ≤0.05 was considered statistically significant. Statistical analysis was performed with SPSS 13.0 statistical software (SPSS Inc., Chicago, IL, USA).
The study complies with the Declaration of Helsinki and was approved by local institutional review boards. Informed consent was obtained from all patients. The database was approved by the French computers and privacy commission.
Results
Features of the study population
The study population comprised 799 patients (410 men and 389 women). The sex ratio was 1.05. The mean age was 75±12 (range 25-100) years, with a mean age of 73±12 years in men and 78±11 years in women (p<0.001); 77% of patients were older than 70 years and 38% were older than 80 years. Most patients were hospitalized in cardiology units (n=607, 76%), 13% (n=106) in internal medicine departments, and 11% (=85) in geriatric units. The mean hospital stay was 10.8±7.0 days and 210 patients (26%) had a stay in intensive care units during hospitalization.
The baseline characteristics of the study population are displayed in table 1. The most frequent risk factors were hypertension (62%) and smoking (35%). Twenty-five per cent of patients were diabetic. Coronary artery disease was identified in 38% of patients (n=302) and valvular disease in 9% (n=72). Non-cardiac comorbidities were frequently observed. Thirty three per cent of patients had atrial fibrillation on baseline ECG.
Ejection fraction was assessed in 662 patients (83%). EF was preserved (≥50%) in 56% of cases (n=368). Characteristics of patients according to EF are presented in tables 2 and 3. Mean hospital stay was similar for patients with reduced or preserved EF (10.6±6.7 versus 10.4±6.6 days, p=0.84). Compared to patients with preserved EF, a greater proportion of those with reduced EF had a stay in intensive care units (24% versus 34%, p=0.005). Patients with preserved EF were significantly older and comprised a greater proportion of women. Patients with HFPEF had more often a history of hypertension, a greater frequency of valvular disease, and less frequently had coronary artery disease or prior myocardial infarction. Peripheral artery disease was more frequent in patients with reduced EF (table 3) .
In-hospital outcome
The in-hospital mortality was 8% (64 deaths). The main cause was acute pulmonary oedema (50%) followed by car-diogenic shock (22%). In patients older than 75 years, the in-hospital mortality rate was 10.6% (51 deaths).
On univariate analysis, patients who died during the index hospitalization were older, had a significantly lower SBP on admission, a higher HR on admission, and more often had coronary artery disease and renal failure. History of hypertension and atrial fibrillation on admission appeared to be related to better outcome. EF was significantly lower in patients who died during hospitalization (table 2). By multivariable logistic regression, the following independent predictors of in-hospital mortality were identified in the overall study population: coronary artery disease (p<0.001), SBP on admission ≤100 mmHg (p=0.004), older age (p=0.001), and HR on admission >100 bpm (p=0.002; table 4). In patients in whom EF was assessed, coronary artery disease, SBP on admission ≤100mm Hg, estimated 
In-hospital outcome according to left ventricular ejection fraction
The in-hospital mortality of the reduced EF group was 8.2% (24 deaths), significantly higher than that of the preserved EF group (10 deaths, 2.7%, p=0.002). In the reduced EF group, all deaths were due to cardiovascular causes. The two main causes were acute pulmonary oedema (50% of deaths, n=12) and cardiogenic shock (37.5% of cases, n=9), followed by sudden death (8.4% of cases, n=2) and stroke (4.2% of cases, n=1). In patients with preserved EF, 90% of deaths were cardiovascular. Acute pulmonary oedema was the cause of death in 40% of cases (n=4), sudden death in 30% (n=3), and cardiogenic shock in 10% (n=1). One patient died of cerebral haemorrhage (10%) and one of acute pancreatitis (10%).
In-hospital death rates of HFPEF patients of ischaemic, hypertensive, and valvular aetiology were not significantly different (3.9%, 2.6% and 2.1%, respectively; overall p value 0.76). After excluding from the HFPEF subset patients with a previous myocardial infarction or with valvular disease, in the remaining group (290 with HFPEF and 294 with reduced EF), reduced EF (<50%) remained associated with higher inhospital death rates (8.2%, n=24 for the reduced EF group versus 2.8%, n=8 for the preserved EF group; p=0.004).
By multivariable logistic regression analysis, propensity scores were estimated for each of the 294 patients in the reduced EF group. The goodness-of-fit (p=0.73) and discriminatory power of the model (C=0.77) were good. One-hundred and eighty five patients with reduced EF were successfully matched. After this matching procedure, no difference in baseline variables was observed between the two groups (table 3). In propensity-matched patients, in-hospital mortality was higher in the reduced EF group (7.6% versus 2.2%, p=0.02).
Discussion
Current epidemiological data on HF are based on clinical trials, hospital series, and several population studies, but few studies have focused on patients hospitalized for a first episode of HF [5, 7, [24] [25] [26] . In the present prospective, hospital-based study we describe the clinical features and inhospital outcome of a cohort of patients admitted to hospital for new-onset HF. Our patients were enrolled from com- This design aimed to eliminate referral bias of hospitalbased studies conducted exclusively in tertiary centres that usually include patients with more severe disease. The clinical profile of our patients is similar to other contemporary HF series with high proportions of elderly patients and women and significant burden of non-cardiac comorbidities [5, 7, [10] [11] [12] . The observed in-hospital mortality in the overall study population was 8%. Older age, coronary artery disease, low SBP on admission, increased HR on admission, renal failure, and reduced EF were identified as independent predictors of in-hospital death. Using logistic regression and propensity scores we demonstrate that the in-hospital mortality of patients with preserved EF is lower compared with that of patients with reduced EF.
Characteristics of patients newly admitted to hospital for heart failure
The incidence of HF increases considerably with age [27] . The mean age of our cohort was 75 years, as in a recent hospital-based study including patients admitted between 1993 and 2001 for new-onset HF [28] . In the Framingham study, the mean age at the time of diagnosis of HF was 76 years [29] . In our study, the sex ratio was 1.05, close to values reported by several authors [28, 29] , but lower than other population-based studies [24, 25] . The frequency of coronary artery disease was probably underestimated in our study as coronary angiography was not performed systematically. Nevertheless, the frequency of coronary artery disease (38%) in our study is similar to that reported in other epidemiological studies of HF, such as the Leicestershire study [28] . Sixty two percent of our patients had hypertension. This figure is lower than values reported in the Framingham study, where 70% of men and 78% of women had a history of hypertension [29] . In the Mayo Clinic study, in 1999, 54% of patients were hypertensive [24] . During hospitalization, EF was assessed in 83% of patients, an acceptable figure compared to frequencies reported in recent studies, ranging between 42 and 84% [7, 18, 26, 30] . HFPEF was diagnosed in 56% of patients in whom EF data were available. Recent data indicate that HFPEF becomes the most frequent form of HF observed in clinical practice [5, 13, 14] . Epidemiological studies have shown that, as in our study, patients with HFPEF are older and more often women, and that HFPEF is mainly due to hypertension [1, 24, 30, 31] .
In-hospital outcome and predictors of death
The prognosis of patients admitted to hospital for HF remains poor [18] . Scarce data exist on the in-hospital outcome of such patients [4] [5] [6] [7] [8] [9] [10] [11] 14] . In our cohort, mortality during hospitalization was 8%, a value identical to the inhospital mortality of patients with de novo acute HF included in the EuroHeart Failure Survey II [32] . However, as reported in EuroHeart Failure Survey I, large variability in hospital death rates associated with HF has been observed in different participating European countries [3] . Hospital death rates ranging between 7.1% and 23.4% have been reported by several European population-based studies [6, 7, 28, 31, 33] . In-hospital fatality rates in American HF populations are lower, ranging from 3.8% to 10% [8, [10] [11] [12] 34] . Differences in studied populations, healthcare providers and standards of care are possible explanations for these findings. Stewart et al. have reported that short-term outcomes following a first admission for HF exhibit significant variation depending mainly on the type of hospital managing the patients [6] . We tried to reduce this bias by including in our cohort patients from all healthcare establishments in the Somme department, community hospitals, private clinics, and a university hospital.
We identified several variables associated with an increased risk of hospital death. Low SBP on admission and coronary artery disease were the strongest predictors in our cohort. Significant correlation between SBP on admission and in-hospital outcomes has been reported in previous studies [8, 10, 12, 34] . Age over 75 years predicted in-hospital death in the overall study population but not in patients with an EF assessment during hospitalization. This was probably due to the fact that an EF assessment was not readily available in very elderly patients hospitalized in geriatric units and managed mostly by non-cardiologists. Renal failure was an independent correlate of in-hospital mortality, in agreement with data from the ADHERE (Acute Decompensated Heart Failure National Registry) database [12] . HFPEF has been extensively studied over the past 10 years. More than 50% of all cases of HF occur in the presence of a preserved EF (≥50%). The long-term prognosis of patients hospitalized for HFPEF is poor. Previous studies have reported that HFPEF patients have slightly lower mortality rates compared to patients with reduced EF with similar morbidity rates [18] , whereas in our experience patients hospitalized for a first episode of HF with preserved or reduced EF had comparable 5-year survival rates [13] .
Some authors report comparable in-hospital death rates in patients with preserved or reduced EF [7] , while in other studies patients with HFPEF experienced lower in-hospital event rates [5, 14] . In the current study, although patients with preserved EF were older, the in-hospital death rate of the group with HFPEF was significantly lower than that of the group with reduced EF. Logistic regression identified reduced EF as independent predictor of in-hospital mortality. To reduce the impact of baseline characteristics we performed a propensity score analysis. After the matching procedure using propensity scores, patients with reduced EF still had higher in-hospital mortality. As expected, cardiogenic shock was more frequent in patients with reduced EF who died during hospitalization compared with patients with preserved EF (37.5% versus 10%). This result is consistent with French data from the EFICA (Epidémiologie Francaise de l'Insuffisance Cardiaque Aiguë) study performed in patients with acute HF, reporting that 18% of patients with cardiogenic shock had preserved EF (>45%) [35] .
Limitations
The diversity of the clinical signs of HF and their lack of specificity can introduce an inclusion bias in epidemiological studies related to an incorrect diagnosis. In our prospective study, the diagnosis of HF was made by the attending physician and then confirmed using the Framingham criteria, widely used in epidemiological surveys. In line with recent recommendations, we adopted the cut-off value of 50% for HFPEF [17] [18] [19] [20] . Echocardiography was not systematically performed during the first hours after the patient's arrival as in all epidemiological studies of this type [24, 30] . Only 17% of patients were treated with beta-blockers on admission, a percentage lower than the frequency of coronary artery disease in our cohort. This represents a lack of adherence to therapeutic guidelines in coronary artery disease and shows that clinicians and general practitioners were cautious in prescribing beta-blocker therapy in this cohort of elderly patients with significant comorbidity enrolled during 2000. More recent cohorts report a better use of beta-blockers in HF patients with coronary artery disease [32] .
Since we did not assess diastolic parameters in this paper, we have used the term "HFPEF" and not the term "diastolic HF". All HFPEF patients had clinical HF and EF ≥50%. Although after myocardial infarction patients often develop systolic LV dysfunction, a limited area of necrosis may result in a preserved global LV systolic function, reflected by an EF ≥50%. Thus, 9% of patients with HFPEF in our cohort had a previous myocardial infarction. The frequency of previous myocardial infarction in patients with HFPEF in recent published series varies between 16% and 24% [14, 26] .
Conclusion
Patients admitted to hospital for a first episode of HF are old, with a high frequency of hypertension and coronary artery disease and significant comorbidities. The hospital outcome of these patients is poor and can be predicted using simple clinical data collected on admission. Important differences exist between patients with HFPEF and those with HF and reduced EF with regard to clinical characteristics and in-hospital mortality.
